Virus-host interactions and therapeutic discovery
The Inserm Institute for Viral and Liver Diseases, University of Strasbourg France, is looking for a talented and motivated scientist/project leader to join Prof. Baumert’s highly ambitious translational program for the discovery of novel targets for cure of hepatitis B virus and SARS-Cov-2 using unique and cutting-edge patient model systems as well scRNASeq technologyin close collaboration with Pharma. A background in virology or immunology would be desirable. Our program is based on key scientific discoveries and knowledge described in Aizarani et al. Nature 2019, Eller et al. Nat. Commun. 2020, Verrier et al. Gut 2020, Crouchet et al. Nat. Commun. 2021, Jühling et al. Gut 2021, Saviano et al. Hepatology 2021.
What we offer
The institute is a world-class organisation of scientific excellence, training, and innovation in the heart of Europe within a high-quality environment of pharma, academia and medical care. The successful candidate will benefit of:
- An international and vibrant state-of-the-art training environment
- Cutting-edge technologies including a single-cell RNASeq platform and the latest patient-derived models
- Close collaborations with pharma and world-class leaders in the field
- Tenure track program at Inserm and Unistra and excellent career opportunities in industry
- For medical doctors: opportunities to receive PhD in translational research
Profile
PhD or MD with a first publication record and ambition to drive an innovative program to success. Strong communicator with excellent command of English, both spoken and written. Drive and motivation to be a project leader. You thrive in a fast-paced and exciting scientific environment with the opportunity for leading and driving a biomedical translational virology research program.
Scientist / Project Leader in Virus-host Interactions
and Therapeutic Discovery for Hepatitis B and SARS-CoV-2
The Inserm Institute for Viral and Liver Diseases, University of Strasbourg France, is looking for a talented and motivated scientist/project leader to join Prof. Baumert’s highly ambitious translational program for the discovery of novel targets for cure of hepatitis B virus and SARS-Cov-2 using unique and cutting-edge patient model systems as well scRNASeq technologyin close collaboration with Pharma. A background in virology or immunology would be desirable. Our program is based on key scientific discoveries and knowledge described in Aizarani et al. Nature 2019, Eller et al. Nat. Commun. 2020, Verrier et al. Gut 2020, Crouchet et al. Nat. Commun. 2021, Jühling et al. Gut 2021, Saviano et al. Hepatology 2021.
What we offer
The institute is a world-class organization of scientific excellence, training, and innovation in the heart of Europe within a high-quality environment of pharma, academia and medical care. The successful candidate will benefit of:
- An international and vibrant state-of-the-art training environment
- Cutting-edge technologies including a single-cell RNASeq platform and the latest patient-derived models
- Close collaborations with pharma and world-class leaders in the field
- Tenure track program at Inserm and Unistra and excellent career opportunities in industry
- For medical doctors: opportunities to receive PhD in translational research
Profile
PhD or MD with a first publication record and ambition to drive an innovative program to success. Strong communicator with excellent command of English, both spoken and written. Drive and motivation to be a project leader. You thrive in a fast-paced and exciting scientific environment with the opportunity for leading and driving a biomedical translational virology research program.
To apply
Please send your motivation letter (why you are interested in this position) and CV (including experience, track record and 2 academic references) to Prof. Thomas Baumert (Thomas.Baumert@unistra.fr) and Dr. Catherine Schuster (Catherine.Schuster@unistra.fr).